Podcast
Questions and Answers
HHV-6 establishes latency in monocytes. What is the primary risk associated with this latent state, especially in immunocompromised individuals?
HHV-6 establishes latency in monocytes. What is the primary risk associated with this latent state, especially in immunocompromised individuals?
- Reactivation leading to serious infections such as encephalitis. (correct)
- Development of Kaposi's sarcoma due to HHV-6 induced immunosuppression.
- The immediate progression to roseola infantum, regardless of prior infection history.
- An increased susceptibility to bacterial infections due to monocyte dysfunction.
Why is Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) classified as an oncovirus?
Why is Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) classified as an oncovirus?
- It integrates its viral DNA into the host genome, causing genomic instability and cancer.
- Its lytic cycle aggressively destroys immune cells, indirectly promoting tumor development.
- It inhibits tumor suppressor proteins like p53, preventing apoptosis and promoting uncontrolled cell proliferation. (correct)
- It directly induces mutations in host DNA, leading to uncontrolled cell growth.
What is the most critical factor that differentiates the clinical management of HHV-6 versus HHV-8 infections?
What is the most critical factor that differentiates the clinical management of HHV-6 versus HHV-8 infections?
- HHV-6 is primarily managed with chemotherapy, while HHV-8 is treated with antiviral medications.
- HHV-6 requires aggressive treatment with radiation therapy, while HHV-8 is managed with supportive care only.
- HHV-6 management focuses on symptom relief, while HHV-8 treatment aims to halt tumor progression, using local and systemic therapies. (correct)
- HHV-6 infections are treated with antibiotics to prevent secondary bacterial infections, while HHV-8 requires no intervention.
In immunocompromised individuals, how does the reactivation of HHV-6 typically manifest, and what cell types are primarily involved in this process?
In immunocompromised individuals, how does the reactivation of HHV-6 typically manifest, and what cell types are primarily involved in this process?
What feature of HHV-8's lytic phase contributes most significantly to the pathogenesis of Kaposi's sarcoma?
What feature of HHV-8's lytic phase contributes most significantly to the pathogenesis of Kaposi's sarcoma?
How do the modes of transmission of HHV-6 and HHV-8 most critically influence the epidemiology and at-risk populations for the associated diseases?
How do the modes of transmission of HHV-6 and HHV-8 most critically influence the epidemiology and at-risk populations for the associated diseases?
How does the mechanism of HHV-8's latency differ fundamentally from that of HHV-6, regarding their impact on cellular function and potential for oncogenesis?
How does the mechanism of HHV-8's latency differ fundamentally from that of HHV-6, regarding their impact on cellular function and potential for oncogenesis?
In diagnosing roseola infantum, which clinical feature is most critical in differentiating it from other common childhood exanthems, such as measles or rubella?
In diagnosing roseola infantum, which clinical feature is most critical in differentiating it from other common childhood exanthems, such as measles or rubella?
How does the role of dendritic cells in HHV-6 infection contribute to the virus's ability to disseminate within the host?
How does the role of dendritic cells in HHV-6 infection contribute to the virus's ability to disseminate within the host?
What is the primary reason why antiviral treatments like acyclovir or ganciclovir are selectively used in severe cases of HHV-6 infection in immunocompromised individuals?
What is the primary reason why antiviral treatments like acyclovir or ganciclovir are selectively used in severe cases of HHV-6 infection in immunocompromised individuals?
Flashcards
Human Herpes Virus 6 (HHV-6)
Human Herpes Virus 6 (HHV-6)
Double-stranded linear DNA virus belonging to the Herpesviridae family, subfamily Betaherpesvirinae, genus Roseolovirus, transmitted via respiratory secretions.
Roseola Infantum
Roseola Infantum
Common childhood disease caused by primary HHV-6 infection, characterized by high fever followed by a maculopapular rash.
HHV-6 Pathogenesis
HHV-6 Pathogenesis
Through respiratory secretions, the virus attaches to dendritic cells, presents antigens to T cells, migrates to lymph nodes, infecting CD4+ T lymphocytes. Can enter a latent state in monocytes.
Human Herpes Virus 8 (HHV-8/KSHV)
Human Herpes Virus 8 (HHV-8/KSHV)
Signup and view all the flashcards
Kaposi's Sarcoma (KS)
Kaposi's Sarcoma (KS)
Signup and view all the flashcards
HHV-8 Transmission and Entry
HHV-8 Transmission and Entry
Signup and view all the flashcards
HHV-8 Latent Phase
HHV-8 Latent Phase
Signup and view all the flashcards
HHV-8 Lytic Phase
HHV-8 Lytic Phase
Signup and view all the flashcards
Kaposi's Sarcoma Types
Kaposi's Sarcoma Types
Signup and view all the flashcards
Kaposi's Sarcoma Diagnosis
Kaposi's Sarcoma Diagnosis
Signup and view all the flashcards
Study Notes
- Human Herpes Virus 6 (HHV-6) and Human Herpes Virus 8 (HHV-8) are double-stranded linear DNA viruses
HHV-6
- Belongs to the Herpesviridae family, Betaherpesvirinae subfamily, and Roseolovirus genus
- Transmitted through respiratory secretions
- Attaches to dendritic cells (skin, nose, lungs, stomach, intestines) which present antigens to T cells
- Migrates to lymph nodes, infecting CD4+ T lymphocytes where it replicates efficiently
- Undergoes the lytic cycle within T cells, destroying them and infecting neighboring cells
- Can also replicate in monocytes, macrophages, NK cells, astrocytes, megakaryocytes, and glial cells, but less efficiently
- Enters a latent state in monocytes, potentially reactivating in immunocompromised individuals, causing serious infections like encephalitis
- Primary infection causes roseola infantum (exanthem subitum or sixth disease)
- Common in children aged 6 months to 2 years.
- Incubation period: 1-2 weeks
- Symptoms: High fever (up to 40°C or 104°F) lasting 3-5 days, peri-orbital edema, acute otitis media, rhinorrhea, cough, vomiting, diarrhea, bulging fontanelle, lymphadenopathy, and Nagayama spots
- After fever subsides, a maculopapular rash appears on the neck, trunk, face, and extremities, lasting a few hours to two days
- Diagnosis: Clinical findings, PCR to identify viral DNA, and serological tests for IgG antibodies against HHV-6
- Treatment: Supportive care (antipyretics, increased fluid intake); antivirals in severe cases
HHV-8
- Also called Kaposi's sarcoma-associated herpesvirus (KSHV)
- Belongs to the family of human gammaherpesviruses
- One of the seven known oncoviruses, specifically causing Kaposi's sarcoma (KS)
- Large, double-stranded linear DNA virus
- Surrounded by an icosahedral capsid, a protein layer called the tegument, and an envelope with viral glycoproteins
- Transmitted through sexual contact
- Enters B cells, endothelial cells, macrophages, and epithelial cells
- Latent Phase: Virus remains in the cell without destroying it, expresses latency-associated nuclear antigen (LANA-1), inhibiting tumor suppressor protein p53, preventing apoptosis, leading to uncontrolled cellular proliferation
- Lytic Phase: Virus replicates, producing new viruses that destroy the cell and infect neighboring cells
- Healthy immune system limits infection due to humoral (antibodies) and cellular (cytotoxic T cells) immune responses
- Immunocompromised individuals are at higher risk
Clinical Presentation of Kaposi’s Sarcoma
- Four types: Classic, endemic, epidemic (AIDS-associated), and immunosuppression therapy-related
- Characterized by vascular proliferation and dark or violaceous plaques on the skin, mouth, GI tract, or lungs
- Lesions resemble bruises, which can grow into nodules and merge
- Other symptoms: weight loss, nausea, vomiting, diarrhea, bleeding, malabsorption, shortness of breath, chest pain, cough, hemoptysis
Diagnosis
- Biopsy of lesions, microscopic examination showing spindle cells, immunohistochemical staining for LANA-1, and PCR for viral DNA
Treatment
- Aimed at stopping the progression of KS
- Local treatments (radiation therapy, cryosurgery) for skin lesions
- Chemotherapy (doxorubicin, daunorubicin, thalidomide, paclitaxel) for widespread disease
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.